Delivery Order SPE2DB20D2014-SPE2DB25FC84X
- Not listed
- The Defense Logistics Agency (DLA) awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion scheduled for September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,531.20 with a completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,936.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of September 2, 2025. This is an unset-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $9,451.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $13,511.84 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric typhoid vaccine supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a delivery against...
- The Defense Logistics Agency awarded a $27,961.22 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes. The contract, which is non-set-aside and competitively awarded, has a firm fixed price structure with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,679.97 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML vaccine supply. This non-competitive delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025, utilizing firm fixed pricing. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical supply chain requirements. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,348.50 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 11, 2025, with completion expected by August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The vaccine product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $68,990 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This firm fixed-price, competitively awarded contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC84XDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes, valued at $13,798.00. This firm fixed-price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without set-aside designation through competitive procurement. This delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supplies pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, vaccines, syringes, and related medical commodities. AmerisourceBergen's extensive federal contract portfolio with the DLA Medical Supply Chain demonstrates its established capability as a critical vendor serving military and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 8/27/25 |